P. Martin Paslick - 17 Feb 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP and CIO
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 17 Feb 2023
Transactions value $: $-943,333
Form type: 4
Filing time: 22 Feb 2023, 19:08:40 UTC
Previous filing: 01 Feb 2023
Next filing: 06 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+9,120	+41.2%	$0.000000	31,266	17 Feb 2023	Direct	F1
transaction	HCA	Common Stock	Tax liability	$-943,333	-3,589	-11.5%	$262.84	27,677	17 Feb 2023	Direct
holding	HCA	Common Stock						3,000	17 Feb 2023	by 2021 Trust
holding	HCA	Common Stock						60,000	17 Feb 2023	By PMP 2020 Trust
holding	HCA	Common Stock						63,999	17 Feb 2023	by RJP 2020 Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 29, 2020, the reporting person was granted 4,560 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On January 29, 2020, the reporting person was granted 4,560 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.